AF
ABUS icon

Advisornet Financial’s Arbutus Biopharma ABUS Stock Holding History

Advisornet Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-272
Closed -$1K – 1867
2021
Q2 		$1K Hold
272
– – ﹤0.01% 1726
2021
Q1 		$1K Hold
272
– – ﹤0.01% 1671
2020
Q4 		$1K Hold
272
– – ﹤0.01% 1577
2020
Q3 		$1K Buy
+272
New +$827 ﹤0.01% 1600

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Advisornet Financial's ABUS Position: Q3 2021 in Review

Advisornet Financial sold out of Arbutus Biopharma (ABUS) in Q3 2021, closing a stake of 272 shares — an estimated $1K sold.

Advisornet Financial first reported a position in ABUS in Q3 2020 and held it in 4 quarters. The position peaked at $1K in Q2 2021. 99 funds tracked by Wall St. Rank hold ABUS as of Q3 2021.

  • Advisornet Financial reported no remaining Arbutus Biopharma position as of Q3 2021 after selling out during the quarter.
  • Advisornet Financial sold 272 Arbutus Biopharma shares in Q3 2021, an estimated $1K.
  • Advisornet Financial first reported a position in Arbutus Biopharma in Q3 2020 and held it in 4 quarters.
  • Advisornet Financial's Arbutus Biopharma position peaked at $1K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2021.

Based on Advisornet Financial's 13F filing for Q3 2021, filed 15 Oct 2021.